Terms: = Endocrine gland cancer AND BTK, AGMX1, 695, ENSG00000010671, XLA, IMD1, RP1-164F3_2, MGC126262, BPK, ATK, MGC126261, Q06187, AT, PSCTK1
95360 results:
1. Active surveillance is a feasible and safe strategy in selected patients with papillary thyroid cancer and suspicious cervical lymph nodes detected after thyroidectomy.
Solórzano M; Lustig N; Mosso L; Espinoza M; Santana R; Gonzalez H; Montero PH; Cruz F; Solar A; Domínguez JM
Arch Endocrinol Metab; 2024 May; 68():e230146. PubMed ID: 38709151
[TBL] [Abstract] [Full Text] [Related]
2. Identification and Economic Evaluation of Differentiated Thyroid cancer Care Consumption Patterns Using Sequence Analysis.
Demeulemeester R; Grosclaude P; Grunenwald S; Saint-Pierre P; Savy N; Costa N
Int J Public Health; 2024; 69():1606664. PubMed ID: 38707870
[No Abstract] [Full Text] [Related]
3. The prophylactic antiemetic therapies in management of differentiated thyroid cancer patients with radioactive iodine therapy: a single-center, non-randomized clinical trial.
Li X; Cao J; Wang W; Zhu X; Sun Y; Song L; Zhang W; Han Y
Front Endocrinol (Lausanne); 2024; 15():1310223. PubMed ID: 38706697
[TBL] [Abstract] [Full Text] [Related]
4. piR-1919609 Is an Ideal Potential Target for Reversing Platinum Resistance in Ovarian cancer.
Yan Y; Tian D; Zhao B; Li Z; Huang Z; Li K; Chen X; Zhou L; Feng Y; Yang Z
Technol Cancer Res Treat; 2024; 23():15330338241249692. PubMed ID: 38706262
[TBL] [Abstract] [Full Text] [Related]
5. NB compounds are potent and efficacious FOXM1 inhibitors in high-grade serous ovarian cancer cells.
Liu C; Vorderbruggen M; Muñoz-Trujillo C; Kim SH; Katzenellenbogen JA; Katzenellenbogen BS; Karpf AR
J Ovarian Res; 2024 May; 17(1):94. PubMed ID: 38704607
[TBL] [Abstract] [Full Text] [Related]
6. Perioperative management of a patient with unexpectedly detected early-stage ovarian mucinous carcinoma combined with progressive bulbar paralysis: a case report and literature review.
Zhang D; Xu R; Huo T; Liu Y; Hao Z; Sun Y; Xi X; Du X; Wang L; Du J
BMC Womens Health; 2024 May; 24(1):274. PubMed ID: 38704534
[TBL] [Abstract] [Full Text] [Related]
7. Smoking history is associated with reduced efficacy of neoadjuvant therapy in pancreatic adenocarcinoma.
Akumuo RC; Reddy SP; Westwood C; Devarajan K; Barrak D; Reddy SS; Villano AM
J Gastrointest Surg; 2024 May; 28(5):605-610. PubMed ID: 38704197
[TBL] [Abstract] [Full Text] [Related]
8. Comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in patients with newly diagnosed homologous recombination-deficient stage III/IV ovarian cancer: study protocol for cohort C of the open-label, phase 2, randomized controlled multicenter OPAL trial.
Belotte J; Felicetti B; Baines AJ; YoussefAgha A; Rojas-Espaillat L; Ortiz AG; Provencher D; Vázquez RM; Cortijo LG; Zeng X
Trials; 2024 May; 25(1):301. PubMed ID: 38702828
[TBL] [Abstract] [Full Text] [Related]
9. Factors influencing TSH suppression efficacy in postoperative papillary thyroid carcinoma patients: a retrospective cohort study.
Zhang Q; Zhong ZZ; Wu T; He YQ
BMC Surg; 2024 May; 24(1):133. PubMed ID: 38702652
[TBL] [Abstract] [Full Text] [Related]
10. Predictors of Blood Transfusion in Patients Undergoing Cytoreductive Surgeries for Ovarian Malignancy.
Pearce JV; Zhao J; Randall L; Sullivan SA; Miller D; Tossas K
South Med J; 2024 May; 117(5):266-271. PubMed ID: 38701848
[TBL] [Abstract] [Full Text] [Related]
11. Assessing the relative effectiveness of various ultrasound-guided ablation techniques for treating benign thyroid nodules: A systematic review and network meta-analysis.
Sun X; Chen J; Zou Y; Lei J; Liu W
Medicine (Baltimore); 2024 May; 103(18):e38014. PubMed ID: 38701262
[TBL] [Abstract] [Full Text] [Related]
12. OTUB2 silencing promotes ovarian cancer via mitochondrial metabolic reprogramming and can be synthetically targeted by CA9 inhibition.
Nan Y; Wu X; Luo Q; Chang W; Zhao P; Zhang L; Liu Z
Proc Natl Acad Sci U S A; 2024 May; 121(19):e2315348121. PubMed ID: 38701117
[TBL] [Abstract] [Full Text] [Related]
13. Analysis of chemoresistance characteristics and prognostic relevance of postoperative gemcitabine adjuvant chemotherapy in pancreatic cancer.
Ren J; Wu S; Su T; Ding J; Chen F; Li J; Wang Z; Han L; Wu Z
Cancer Med; 2024 May; 13(9):e7229. PubMed ID: 38698688
[TBL] [Abstract] [Full Text] [Related]
14. Parathyroid tumors in the 5th edition of the WHO Classification of Tumors of the endocrine Organs.
J D
Cesk Patol; 2024; 60(1):68-70. PubMed ID: 38697830
[TBL] [Abstract] [Full Text] [Related]
15. Changes in the diagnosis of thyroid tumours in the 5th edition of the WHO classification of endocrine neoplasms.
J D
Cesk Patol; 2024; 60(1):59-63. PubMed ID: 38697828
[TBL] [Abstract] [Full Text] [Related]
16. Our experience with robotic-assisted thymic surgery.
Podhráský M; Tvrdoň J; Schützner J
Rozhl Chir; 2024; 103(2):40-47. PubMed ID: 38697812
[TBL] [Abstract] [Full Text] [Related]
17. NANOG controls testicular germ cell tumour stemness through regulation of MIR9-2.
Cardenas RP; Zyoud A; McIntyre A; Alberio R; Mongan NP; Allegrucci C
Stem Cell Res Ther; 2024 May; 15(1):128. PubMed ID: 38693576
[TBL] [Abstract] [Full Text] [Related]
18. A novel method of tunneling retroperitoneoscopic adrenalectomy: a prospective study.
Zhang P; Pei Y; Zhi Y; Sun F
BMC Urol; 2024 Apr; 24(1):101. PubMed ID: 38689249
[TBL] [Abstract] [Full Text] [Related]
19. Antitumor activity of extracellular signal-regulated kinases 1/2 inhibitor BVD-523 (ulixertinib) on thyroid cancer cells.
Chen Y; Xiao X; Hu G; Liu R; Xue J
J Cancer Res Ther; 2024 Apr; 20(2):570-577. PubMed ID: 38687926
[TBL] [Abstract] [Full Text] [Related]
20. Accuracy and diagnostic performance of the Bethesda system for reporting thyroid cytopathology in a tertiary endocrine surgical referral center in Belgium.
Kinet S; Cornette H; Van Den Heede K; Brusselaers N; Van Slycke S
World J Surg; 2024 Feb; 48(2):386-392. PubMed ID: 38686788
[TBL] [Abstract] [Full Text] [Related]
[Next]
